Stocks
Tekla Life Sciences InvestorsHQL
NYSEFinancial ServicesAsset Management$16.37-1.50%
A closed-end investment fund that provides public market exposure to biotechnology, pharmaceutical, and broader life sciences companies. The portfolio is actively managed and typically holds a mix of large-cap drugmakers and smaller biotech firms, with a mandate to generate long-term capital appreci...
Market Cap: $472.6M52W Range: $10.55 – $17.80
Congressional Interest in Tekla Life Sciences Investors (HQL)
2 members of Congress have disclosed 8 trades in Tekla Life Sciences Investors (HQL), a Financial Services company. The buy/sell breakdown shows 5 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
8
Unique Politicians
2
Buys
5
Sells
3
Who in Congress Is Trading HQL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-10-04 | Thomas R Carper | sell | $1K – $15K |
| 2020-02-22 | Thomas R Carper | buy | $1K – $15K |